Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma
- PMID: 37069006
- DOI: 10.1016/j.joim.2023.03.009
Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma
Abstract
Objective: Although there have been improvements in targeted therapy and immunotherapy, the majority of lung adenocarcinoma (LUAD) patients still lack effective therapies. Consequently, it is urgent to screen for new diagnosis biomarkers and pharmacological targets. Junctional adhesion molecule-like protein (JAML) was considered to be an oncogenic protein and may be a novel therapeutic target in LUAD. Kaempferol is a natural flavonoid that exhibits antitumor activities in LUAD. However, the effect of kaempferol on JAML is still unknown.
Methods: Small interfering RNA was used to knockdown JAML expression. The cell viability was determined using the cell counting kit-8 assay. The proliferation of LUAD cells was evaluated using the 5-ethynyl-2'-deoxyuridine incorporation assay. The migration and invasion of LUAD cells were evaluated by transwell assays. Molecular mechanisms were explored by Western blotting.
Results: JAML knockdown suppressed proliferation, migration and invasion of LUAD cells, and JAML deficiency restrained epithelial-mesenchymal transition (EMT) via inactivating the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway. Using a PI3K activator (740Y-P), rescue experiments showed that phenotypes to JAML knockdown in LUAD cells were dependent on the PI3K/AKT/mTOR pathway. Kaempferol also inhibited proliferation, migration and invasion of A549 and H1299 cells and partially suppressed EMT through the PI3K/AKT/mTOR pathway. Knockdown of JAML ameliorated the inhibitory effect of kaempferol on LUAD cells. Kaempferol exerted anticancer effects by targeting JAML.
Conclusion: JAML is a novel target for kaempferol against LUAD cells. Please cite this article as: Wu Q, Wang YB, Che XW, Wang H, Wang W. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. J Integr Med. 2023; 21(3): 268-276.
Keywords: Invasion; Junctional adhesion molecule-like protein; Kaempferol; Lung adenocarcinoma; Migration; Proliferation.
Copyright © 2023 Journal of Integrative Medicine Editorial Office. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.J Transl Med. 2022 Jun 7;20(1):260. doi: 10.1186/s12967-022-03457-w. J Transl Med. 2022. PMID: 35672776 Free PMC article.
-
[GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway].Zhongguo Fei Ai Za Zhi. 2024 Oct 20;27(10):735-744. doi: 10.3779/j.issn.1009-3419.2024.101.27. Zhongguo Fei Ai Za Zhi. 2024. PMID: 39631830 Free PMC article. Chinese.
-
Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.Med Sci Monit. 2020 Feb 28;26:e920351. doi: 10.12659/MSM.920351. Med Sci Monit. 2020. PMID: 32108133 Free PMC article.
-
Regulation of Ferroptosis in Lung Adenocarcinoma.Int J Mol Sci. 2023 Sep 27;24(19):14614. doi: 10.3390/ijms241914614. Int J Mol Sci. 2023. PMID: 37834062 Free PMC article. Review.
-
Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways.Molecules. 2022 Dec 13;27(24):8864. doi: 10.3390/molecules27248864. Molecules. 2022. PMID: 36557997 Free PMC article. Review.
Cited by
-
The distinct biological role of JAML positions it as a promising target for treating human cancers and a range of other diseases.Front Immunol. 2025 Jun 25;16:1558488. doi: 10.3389/fimmu.2025.1558488. eCollection 2025. Front Immunol. 2025. PMID: 40636111 Free PMC article. Review.
-
JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment.In Vitro Cell Dev Biol Anim. 2024 Apr;60(4):382-396. doi: 10.1007/s11626-024-00881-8. Epub 2024 Apr 16. In Vitro Cell Dev Biol Anim. 2024. PMID: 38625487
-
LncRNA OIP5-AS1 suppresses lung adenocarcinoma progression and modulates macrophage polarization through the miR-429/DOCK4 regulatory axis.Front Pharmacol. 2025 May 20;16:1569644. doi: 10.3389/fphar.2025.1569644. eCollection 2025. Front Pharmacol. 2025. PMID: 40529490 Free PMC article.
-
M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges.Front Oncol. 2025 Jul 16;15:1622359. doi: 10.3389/fonc.2025.1622359. eCollection 2025. Front Oncol. 2025. PMID: 40740874 Free PMC article. Review.
-
Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.MedComm (2020). 2025 Mar 10;6(3):e70126. doi: 10.1002/mco2.70126. eCollection 2025 Mar. MedComm (2020). 2025. PMID: 40066226 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous